LONA
LeonaBio, Inc.
Next earnings Aug 5, 2026 · consensus $-1.30 EPS
Last earnings +4.7% on 2026-05-07
$9.40
▲ +8.17%$9.40▲ +217.57%
over 1Y
L $2.95EODHDH $11.68
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+8.2%
1W+13.7%
1M-4.2%
3M+4.8%
YTD+35.1%
1Y+217.6%
Sell
Conviction
Horizon
Medium (3–12mo)
Street · 9 analysts
Buy
Mixed signals in the latest filings.
Return on equity -380.0% · latest
LeonaBio, Inc. shows limited reported revenue, and -380.0% ROE.
Financials · annual, by fiscal year
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Gross profit | — | — | — | — | — |
| Operating income | -$64.0M | -$104M | -$125M | -$101M | -$102M |
| Net income | -$54.9M | -$95.6M | -$118M | -$96.9M | -$106M |
| Diluted EPS | -$1.49 | -$2.53 | -$3.09 | -$25.19 | -$24.70 |
| Net margin | — | — | — | — | — |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Key statistics
Valuation
Enterprise value$298M
EV / EBITDA—
EV / Sales—
EV / FCF—
P / FCF—
PEG (trailing)—
Earnings yield-28.8%
FCF yield-12.5%
Quality & risk
ROIC (est.)-290.7%
Free cash flow-$45.8M
Total debt—
Net cash$69.3M
Piotroski F-Score2/6
Capital returns
Buyback yield—
Dividend yield (est.)—
Shareholder yield—
Shares Δ YoY+1.9%
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Disclosure timeline
SEC · 8-Ks + reportsSome governance/structural items recently, but no outright red flags.
Recent filings
all on EDGAR ↗4Period ending 2026-06-232026-06-24open ↗4Period ending 2026-06-232026-06-24open ↗4Period ending 2026-06-232026-06-24open ↗4Period ending 2026-06-232026-06-24open ↗4Period ending 2026-06-232026-06-24open ↗4Period ending 2026-06-232026-06-24open ↗4Period ending 2026-06-232026-06-24open ↗4Period ending 2026-06-232026-06-24open ↗4Period ending 2026-06-232026-06-24open ↗8-KPeriod ending 2026-06-222026-06-23open ↗SCHEDULE 13GFiling2026-05-15open ↗ARSPeriod ending 2025-12-312026-05-11open ↗
Frequently asked
- Is LeonaBio, Inc. (LONA) a buy?
- LONA currently carries a Sell rating with 2/5 conviction, derived from its latest SEC filings. Mixed signals in the latest filings.
- What is LeonaBio, Inc.'s quality score?
- LONA scores 37.61538461538462/100 (grade F) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.
Sources: SEC EDGAR (CIK 0001620463, latest 10-Q filed 2026-05-07) · EODHD · as of 6/22/2026, 9:51:58 PM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.